Nystatin A3

Nystatin A3 is a lipid of Polyketides (PK) class. Nystatin a3 is associated with abnormalities such as Mycoses, Candidiasis of the genitals and Gigantism. The involved functions are known as Drug Interactions, Process, Synthesis, Fermentation and Anabolism. Nystatin a3 often locates in Cell membrane, Membrane, Protoplasm, Entire oral cavity and integral to membrane. The associated genes with Nystatin A3 are Gene Clusters. The related lipids are Sterols, 1,2-oleoylphosphatidylcholine, Membrane Lipids, DOPE and N-caproylsphingosine.

Cross Reference

Introduction

To understand associated biological information of Nystatin A3, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.

What diseases are associated with Nystatin A3?

Nystatin A3 is suspected in Mycoses, Candidiasis of the genitals, Gigantism and other diseases in descending order of the highest number of associated sentences.

Related references are mostly published in these journals:

Disease Cross reference Weighted score Related literature
Loading... please refresh the page if content is not showing up.

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with Nystatin A3

MeSH term MeSH ID Detail
Vaginosis, Bacterial D016585 10 associated lipids
Pregnancy Complications, Infectious D011251 11 associated lipids
Influenza, Human D007251 11 associated lipids
Candidiasis, Oral D002180 11 associated lipids
HIV Seropositivity D006679 15 associated lipids
Dermatomycoses D003881 17 associated lipids
Mycoses D009181 18 associated lipids
Leishmaniasis D007896 19 associated lipids
Burns D002056 34 associated lipids
Anemia, Sickle Cell D000755 34 associated lipids
Per page 10 20 50 | Total 25

PubChem Associated disorders and diseases

What pathways are associated with Nystatin A3

There are no associated biomedical information in the current reference collection.

PubChem Biomolecular Interactions and Pathways

Link to PubChem Biomolecular Interactions and Pathways

What cellular locations are associated with Nystatin A3?

Related references are published most in these journals:

Location Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What functions are associated with Nystatin A3?


Related references are published most in these journals:

Function Cross reference Weighted score Related literatures

What lipids are associated with Nystatin A3?

Related references are published most in these journals:

Lipid concept Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What genes are associated with Nystatin A3?

Related references are published most in these journals:


Gene Cross reference Weighted score Related literatures

What common seen animal models are associated with Nystatin A3?

There are no associated biomedical information in the current reference collection.

NCBI Entrez Crosslinks

All references with Nystatin A3

Download all related citations
Per page 10 20 50 100 | Total 1594
Authors Title Published Journal PubMed Link
Kristanc L et al. Effects of the pore-forming agent nystatin on giant phospholipid vesicles. 2012 Biochim. Biophys. Acta pmid:22178865
Kaufman DA "Getting to Zero": preventing invasive Candida infections and eliminating infection-related mortality and morbidity in extremely preterm infants. 2012 Early Hum. Dev. pmid:22633513
Khan MA et al. Immune stimulating and therapeutic potential of tuftsin-incorporated nystatin liposomes against Cryptococcus neoformans in leukopenic BALB/C mice. 2012 FEMS Immunol. Med. Microbiol. pmid:22612788
Martins HP et al. Efficacy of fluconazole and nystatin in the treatment of vaginal Candida species. 2012 Acta Derm. Venereol. pmid:21918792
Usta Y Persistent hiccups: an unusual presentation and treatment. 2012 J Pain Symptom Manage pmid:22248794
Shanmughapriya S et al. In vitro actinomycete biofilm development and inhibition by the polyene antibiotic, nystatin, on IUD copper surfaces. 2012 Biofouling pmid:22963125
Blyth CC et al. Chemoprophylaxis of neonatal fungal infections in very low birthweight infants: efficacy and safety of fluconazole and nystatin. 2012 J Paediatr Child Health pmid:22970680
Silva MM et al. Comparison of denture microwave disinfection and conventional antifungal therapy in the treatment of denture stomatitis: a randomized clinical study. 2012 Oral Surg Oral Med Oral Pathol Oral Radiol pmid:22986242
Di Capua R et al. Towards the realization of label-free biosensors through impedance spectroscopy integrated with IDES technology. 2012 Eur. Biophys. J. pmid:22237602
Gerstein AC et al. Parallel genetic changes and nonparallel gene-environment interactions characterize the evolution of drug resistance in yeast. 2012 Genetics pmid:22714405
Kaomongkolgit R et al. Antifungal activity of coronarin D against Candida albicans. 2012 Oral Surg Oral Med Oral Pathol Oral Radiol pmid:22727093
Mima EG et al. Comparison of Photodynamic Therapy versus conventional antifungal therapy for the treatment of denture stomatitis: a randomized clinical trial. 2012 Clin. Microbiol. Infect. pmid:22731617
Fernández Campos F et al. Development and characterization of a novel nystatin-loaded nanoemulsion for the buccal treatment of candidosis: ultrastructural effects and release studies. 2012 J Pharm Sci pmid:22777575
Kalema N et al. Oral antimicrobial rinse to reduce mycobacterial culture contamination among tuberculosis suspects in Uganda: a prospective study. 2012 PLoS ONE pmid:22808020
Bzik VA et al. Mechanisms of action of zinc on rat intestinal epithelial electrogenic ion secretion: insights into its antidiarrhoeal actions. 2012 J. Pharm. Pharmacol. pmid:22471360
Baugé C et al. Regulatory mechanism of transforming growth factor beta receptor type II degradation by interleukin-1 in primary chondrocytes. 2012 Biochim. Biophys. Acta pmid:22425785
Semis R et al. Pharmacokinetics, tissue distribution and immunomodulatory effect of intralipid formulation of nystatin in mice. 2012 J. Antimicrob. Chemother. pmid:22499997
Leibovitz E Strategies for the prevention of neonatal candidiasis. 2012 Pediatr Neonatol pmid:22503254
Bhattacharya S et al. DNA conjugated SWCNTs enter endothelial cells via Rac1 mediated macropinocytosis. 2012 Nano Lett. pmid:22375622
Tester R et al. The use of konjac glucomannan hydrolysates to recover healthy microbiota in infected vaginas treated with an antifungal agent. 2012 Benef Microbes pmid:22348910
Jolivot PA et al. [Assessment of in vitro activity and stability of antifungal suspensions for mouthrinses: to a reappraisal of empiric practices?]. 2012 Pathol. Biol. pmid:22361161
Lee MJ et al. Structural analysis and biosynthetic engineering of a solubility-improved and less-hemolytic nystatin-like polyene in Pseudonocardia autotrophica. 2012 Appl. Microbiol. Biotechnol. pmid:22382166
Al-Dwairi ZN et al. The effect of antifungal agents on surface properties of poly(methyl methacrylate) and its relation to adherence of Candida albicans. 2012 J Prosthodont Res pmid:22841909
Caliceti C et al. Effect of plasma membrane cholesterol depletion on glucose transport regulation in leukemia cells. 2012 PLoS ONE pmid:22859971
Kondo C et al. Predictive genomic biomarkers for drug-induced nephrotoxicity in mice. 2012 J Toxicol Sci pmid:22863853
Kovac M et al. Miconazole and nystatin used as topical antifungal drugs interact equally strongly with warfarin. 2012 J Clin Pharm Ther pmid:21332566
Shinde RB et al. Sensitization of Candida albicans biofilms to various antifungal drugs by cyclosporine A. 2012 Ann. Clin. Microbiol. Antimicrob. pmid:23035934
Bulacio L et al. Oral infections caused by yeasts in patients with head and neck cancer undergoing radiotherapy. Identification of the yeasts and evaluation of their antifungal susceptibility. 2012 J Mycol Med pmid:23518170
Yang Y et al. A chloroplast envelope membrane protein containing a putative LrgB domain related to the control of bacterial death and lysis is required for chloroplast development in Arabidopsis thaliana. 2012 New Phytol. pmid:21916894
Hingston CD et al. Impact of nystatin on Candida and the oral microbiome. 2012 Crit Care pmid:22827886
Giglio M et al. Oral nystatin prophylaxis in surgical/trauma ICU patients: a randomised clinical trial. 2012 Crit Care pmid:22490643
Xu L et al. Epirubicin enhances TRAIL-induced apoptosis in gastric cancer cells by promoting death receptor clustering in lipid rafts. 2011 May-Jun Mol Med Rep pmid:21468584
Brito GN et al. In vitro antifungal susceptibility of Candida spp. oral isolates from HIV-positive patients and control individuals. 2011 Jan-Feb Braz Oral Res pmid:21271179
Chanteloup NK et al. The extra-intestinal avian pathogenic Escherichia coli strain BEN2908 invades avian and human epithelial cells and survives intracellularly. 2011 Vet. Microbiol. pmid:20708353
Berger J et al. Evidence for basolateral Cl- channels as modulators of apical Cl- secretion in pulmonary epithelia of Xenopus laevis. 2011 Am. J. Physiol. Regul. Integr. Comp. Physiol. pmid:21123756
Day TP et al. Imbuing aqueous solubility to amphotericin B and nystatin with a vitamin. 2011 Mol. Pharm. pmid:21141891
Darisipudi MN et al. Polyene macrolide antifungal drugs trigger interleukin-1β secretion by activating the NLRP3 inflammasome. 2011 PLoS ONE pmid:21625424
Seideman JH et al. Alpha particles induce apoptosis through the sphingomyelin pathway. 2011 Radiat. Res. pmid:21631289
Quarmyne MO et al. Volume regulation and KCl cotransport in reticulocyte populations of sickle and normal red blood cells. 2011 Blood Cells Mol. Dis. pmid:21576026
Schulzke JD et al. Anti-diarrheal mechanism of the traditional remedy Uzara via reduction of active chloride secretion. 2011 PLoS ONE pmid:21479205
Chen Y et al. Cholesterol sequestration by nystatin enhances the uptake and activity of endostatin in endothelium via regulating distinct endocytic pathways. 2011 Blood pmid:21482707
Colin D et al. Endocytosis of resveratrol via lipid rafts and activation of downstream signaling pathways in cancer cells. 2011 Cancer Prev Res (Phila) pmid:21467134
Kodedová M et al. Fluorescence method for determining the mechanism and speed of action of surface-active drugs on yeast cells. 2011 BioTechniques pmid:21231924
Stewart AK et al. Functional characterization and modified rescue of novel AE1 mutation R730C associated with overhydrated cation leak stomatocytosis. 2011 Am. J. Physiol., Cell Physiol. pmid:21209359
Fan SR and Liu XP In vitro fluconazole and nystatin susceptibility and clinical outcome in complicated vulvovaginal candidosis. 2011 Mycoses pmid:20406393
Aydemir C et al. Randomised controlled trial of prophylactic fluconazole versus nystatin for the prevention of fungal colonisation and invasive fungal infection in very low birth weight infants. 2011 Arch. Dis. Child. Fetal Neonatal Ed. pmid:20659937
Xu L et al. [Cisplatin enhances TRAIL-induced apoptosis in gastric cancer cells through clustering death receptor 4 into lipid rafts]. 2011 Zhonghua Zhong Liu Za Zhi pmid:22093622
Pendela M et al. Simultaneous determination of lidocaine hydrochloride, hydrocortisone and nystatin in a pharmaceutical preparation by RP-LC. 2011 J Pharm Biomed Anal pmid:21794999
Daniel SJ et al. Is ototopical nystatin ototoxic? A chinchilla model. 2011 Otolaryngol Head Neck Surg pmid:21860059
Semis R et al. Activity of an Intralipid formulation of nystatin in murine systemic candidiasis. 2011 Int. J. Antimicrob. Agents pmid:21839619